Detalhe da pesquisa
1.
Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 21(5): 829-39, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25617806
2.
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.
Am J Hematol
; 89(10): E176-83, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25044365
3.
HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.
Hum Immunol
; 79(6): 403-412, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29605688
4.
Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.
Arch Immunol Ther Exp (Warsz)
; 64(Suppl 1): 63-71, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27933342
5.
Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.
Cell Biochem Biophys
; 65(3): 321-33, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23076633